XML 57 R45.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Collaborative Research, Development, and License Agreements - Additional Information (Details) - USD ($)
 1 Months Ended 12 Months Ended
Dec. 05, 2022
Feb. 22, 2022
May 31, 2011
Mar. 31, 2009
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2016
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Total Revenues         $ 109,000 $ 370,000  
Licensing Agreements [Member]              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Amortization expense of licenses         $ 5,000 82,000  
Weighted average remaining amortization period for all licenses         3 years    
Annual amortization expense of licenses year 1         $ 3,000    
Annual amortization expense of licenses year 2         3,000    
Annual amortization expense of licenses year 3         3,000    
Annual amortization expense of licenses year 4         3,000    
Annual amortization expense of licenses year 5         3,000    
BICO Group AB [Member]              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Nonrefundable upfront fee paid   $ 1,500,000          
Total Revenues   $ 1,500,000     109,000 370,000  
University of Missouri [Member]              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Royalty fees percentage minimum       1.00%      
Royalty fees percentage maximum       3.00%      
Upfront payment $ 50,000,000            
Clemson University [Member]              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Minimum annual royalty paid         40,000 $ 40,000  
Upfront payment         $ 0    
Minimum annual royalty payment due             $ 40,000
Clemson University [Member] | Sublicense Agreements [Member]              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Percentage of royalty revenue from sublicensee         40.00%    
Clemson University [Member] | Licensing Agreements [Member]              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Royalty fees percentage minimum     1.50%        
Royalty fees percentage maximum     3.00%        
Expected expiration year of license agreement     2024-05        
Salk Institute for Biological Studies [Member] | Licensing Agreements [Member]              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Royalty fees percentage minimum         1.00%    
Royalty fees percentage maximum         1.125%    
Percentage of sublicensing revenue         3.50%    
Salk Institute for Biological Studies [Member] | Licensing Agreements [Member] | 45 days of Dosing of First Patient in a Phase III Clinical Trial [Member]              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Milestone payments         $ 500,000    
Salk Institute for Biological Studies [Member] | Licensing Agreements [Member] | 45 days of FDA Approval of First Licensed Product [Member]              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Milestone payments         1,000,000    
Salk Institute for Biological Studies [Member] | Licensing Agreements [Member] | 45 Days of First Commercial Sale of Licensed Product in Territory [Member]              
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]              
Milestone payments         $ 1,500,000